Keywords: shire, biochem, sell, immunogen, stock, biopharmaceutical, firm
Shire BioChem to sell ImmunoGen stock
Article | 24 May 2004
US biopharmaceutical firm ImmunoGen has announced that Shire BioChem intends to sell the over 4 million shares of common stock it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
